TY - JOUR AU - Anzueto, A. AU - Leimer, I. AU - Kesten, S. PY - 2009 DA - 2009// TI - Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes JO - Int J Chron Obstruct Pulmon Dis VL - 4 ID - Anzueto2009 ER - TY - STD TI - Staykova T, Black PN, Chacko EE, Poole P. Prophylactic antibiotic therapy for chronic bronchitis. Cochrane Database Syst Rev 2003(1):CD004105 doi: 10.1002/14651858.CD004105 [published Online First: Epub Date]. ID - ref2 ER - TY - JOUR AU - Herath, S. C. AU - Poole, P. PY - 2013 DA - 2013// TI - Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD) JO - Cochrane Database Syst Rev VL - 11 ID - Herath2013 ER - TY - JOUR AU - Uzun, S. AU - Djamin, R. S. AU - Kluytmans, J. A. AU - Mulder, P. G. AU - van't Veer, N. E. AU - Ermens, A. A. PY - 2014 DA - 2014// TI - Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial JO - Lancet Respir Med VL - 2 UR - https://doi.org/10.1016/S2213-2600(14)70019-0 DO - 10.1016/S2213-2600(14)70019-0 ID - Uzun2014 ER - TY - STD TI - Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JA, Jr., Criner GJ, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011;365(8):689–98. doi:10.1056/NEJMoa1104623. published Online First: Epub Date. ID - ref5 ER - TY - JOUR AU - Blasi, F. AU - Damato, S. AU - Cosentini, R. AU - Tarsia, P. AU - Raccanelli, R. AU - Centanni, S. PY - 2002 DA - 2002// TI - Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment JO - Thorax VL - 57 UR - https://doi.org/10.1136/thorax.57.8.672 DO - 10.1136/thorax.57.8.672 ID - Blasi2002 ER - TY - JOUR AU - Wu, L. AU - Skinner, S. J. AU - Lambie, N. AU - Vuletic, J. C. AU - Blasi, F. AU - Black, P. N. PY - 2000 DA - 2000// TI - Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease JO - Am J Respir Crit Care Med VL - 162 ID - Wu2000 ER - TY - JOUR AU - Seemungal, T. A. AU - Wedzicha, J. A. AU - MacCallum, P. K. AU - Johnston, S. L. AU - Lambert, P. A. PY - 2002 DA - 2002// TI - Chlamydia pneumoniae and COPD exacerbation JO - Thorax VL - 57 UR - https://doi.org/10.1136/thorax.57.12.1087-a DO - 10.1136/thorax.57.12.1087-a ID - Seemungal2002 ER - TY - JOUR AU - Papaetis, G. S. AU - Anastasakou, E. AU - Orphanidou, D. PY - 2009 DA - 2009// TI - Chlamydophila pneumoniae infection and COPD: more evidence for lack of evidence? JO - Eur J Intern Med VL - 20 UR - https://doi.org/10.1016/j.ejim.2009.05.006 DO - 10.1016/j.ejim.2009.05.006 ID - Papaetis2009 ER - TY - JOUR AU - Strachan, D. P. AU - Carrington, D. AU - Mendall, M. AU - Butland, B. K. AU - Yarnell, J. W. AU - Elwood, P. PY - 2000 DA - 2000// TI - Chlamydia pneumoniae serology, lung function decline, and treatment for respiratory disease JO - Am J Respir Crit Care Med VL - 161 UR - https://doi.org/10.1164/ajrccm.161.2.9904055 DO - 10.1164/ajrccm.161.2.9904055 ID - Strachan2000 ER - TY - JOUR AU - Beaty, C. D. AU - Grayston, J. T. AU - Wang, S. P. AU - Kuo, C. C. AU - Reto, C. S. AU - Martin, T. R. PY - 1991 DA - 1991// TI - Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease JO - Am Rev Respir Dis VL - 144 UR - https://doi.org/10.1164/ajrccm/144.6.1408 DO - 10.1164/ajrccm/144.6.1408 ID - Beaty1991 ER - TY - JOUR AU - Banerjee, D. AU - Honeybourne, D. AU - Khair, O. A. PY - 2004 DA - 2004// TI - The effect of oral clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomized controlled trial JO - Treat Respir Med VL - 3 UR - https://doi.org/10.2165/00151829-200403010-00007 DO - 10.2165/00151829-200403010-00007 ID - Banerjee2004 ER - TY - JOUR AU - Blasi, F. AU - Bonardi, D. AU - Aliberti, S. AU - Tarsia, P. AU - Confalonieri, M. AU - Amir, O. PY - 2010 DA - 2010// TI - Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy JO - Pulm Pharmacol Ther VL - 23 UR - https://doi.org/10.1016/j.pupt.2009.12.002 DO - 10.1016/j.pupt.2009.12.002 ID - Blasi2010 ER - TY - JOUR AU - He, Z. Y. AU - Ou, L. M. AU - Zhang, J. Q. AU - Bai, J. AU - Liu, G. N. AU - Li, M. H. PY - 2010 DA - 2010// TI - Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease JO - Respiration VL - 80 UR - https://doi.org/10.1159/000321374 DO - 10.1159/000321374 ID - He2010 ER - TY - JOUR AU - Seemungal, T. A. AU - Wilkinson, T. M. AU - Hurst, J. R. AU - Perera, W. R. AU - Sapsford, R. J. AU - Wedzicha, J. A. PY - 2008 DA - 2008// TI - Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations JO - Am J Respir Crit Care Med VL - 17 UR - https://doi.org/10.1164/rccm.200801-145OC DO - 10.1164/rccm.200801-145OC ID - Seemungal2008 ER - TY - JOUR AU - Suzuki, T. AU - Yanai, M. AU - Yamaya, M. AU - Satoh-Nakagawa, T. AU - Sekizawa, K. AU - Ishida, S. PY - 2001 DA - 2001// TI - Erythromycin and common cold in COPD JO - Chest VL - 120 UR - https://doi.org/10.1378/chest.120.3.730 DO - 10.1378/chest.120.3.730 ID - Suzuki2001 ER - TY - JOUR AU - Sethi, S. AU - Jones, P. W. AU - Theron, M. S. AU - Miravitlles, M. AU - Rubinstein, E. AU - Wedzicha, J. A. PY - 2010 DA - 2010// TI - Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial JO - Respiratory research VL - 11 UR - https://doi.org/10.1186/1465-9921-11-10 DO - 10.1186/1465-9921-11-10 ID - Sethi2010 ER - TY - STD TI - Evans DJ, Bara AI, Greenstone M. Prolonged antibiotics for purulent bronchiectasis. Cochrane Database Syst Rev. 2003(4):CD001392 doi:10.1002/14651858.CD001392 [published Online First: Epub Date]. ID - ref18 ER - TY - JOUR AU - Schultz, M. J. PY - 2004 DA - 2004// TI - Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis JO - J Antimicrob Chemother VL - 54 UR - https://doi.org/10.1093/jac/dkh309 DO - 10.1093/jac/dkh309 ID - Schultz2004 ER - TY - JOUR AU - Altenburg, J. AU - Graaff, C. S. AU - Stienstra, Y. AU - Sloos, J. H. AU - van Haren, E. H. AU - Koppers, R. J. PY - 2013 DA - 2013// TI - Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial JO - JAMA VL - 309 UR - https://doi.org/10.1001/jama.2013.1937 DO - 10.1001/jama.2013.1937 ID - Altenburg2013 ER - TY - JOUR AU - Serisier, D. J. AU - Martin, M. L. AU - McGuckin, M. A. AU - Lourie, R. AU - Chen, A. C. AU - Brain, B. PY - 2013 DA - 2013// TI - Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial JO - JAMA VL - 309 UR - https://doi.org/10.1001/jama.2013.2290 DO - 10.1001/jama.2013.2290 ID - Serisier2013 ER - TY - JOUR AU - Wong, C. AU - Jayaram, L. AU - Karalus, N. AU - Eaton, T. AU - Tong, C. AU - Hockey, H. PY - 2012 DA - 2012// TI - Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial JO - Lancet VL - 380 UR - https://doi.org/10.1016/S0140-6736(12)60953-2 DO - 10.1016/S0140-6736(12)60953-2 ID - Wong2012 ER - TY - JOUR AU - Brill, S. E. AU - Law, M. AU - El-Emir, E. AU - Allinson, J. P. AU - James, P. AU - Maddox, V. PY - 2015 DA - 2015// TI - Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial JO - Thorax ID - Brill2015 ER - TY - JOUR AU - Martinez, F. J. AU - Curtis, J. L. AU - Albert, R. PY - 2008 DA - 2008// TI - Role of macrolide therapy in chronic obstructive pulmonary disease JO - Int J Chron Obstruct Pulmon Dis VL - 3 ID - Martinez2008 ER - TY - JOUR AU - Ray, W. A. AU - Murray, K. T. AU - Hall, K. AU - Arbogast, P. G. AU - Stein, C. M. PY - 2012 DA - 2012// TI - Azithromycin and the risk of cardiovascular death JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1003833 DO - 10.1056/NEJMoa1003833 ID - Ray2012 ER - TY - JOUR AU - Hammerschlag, M. R. AU - Chirgwin, K. AU - Roblin, P. M. AU - Gelling, M. AU - Dumornay, W. AU - Mandel, L. PY - 1992 DA - 1992// TI - Persistent infection with Chlamydia pneumoniae following acute respiratory illness JO - Clin Infect Dis VL - 14 UR - https://doi.org/10.1093/clinids/14.1.178 DO - 10.1093/clinids/14.1.178 ID - Hammerschlag1992 ER - TY - JOUR AU - Hammerschlag, M. R. AU - Qumei, K. K. AU - Roblin, P. M. PY - 1992 DA - 1992// TI - In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae JO - Antimicrob Agents Chemother VL - 36 UR - https://doi.org/10.1128/AAC.36.7.1573 DO - 10.1128/AAC.36.7.1573 ID - Hammerschlag1992 ER - TY - JOUR AU - Redelmeier, D. A. AU - Guyatt, G. H. AU - Goldstein, R. S. PY - 1996 DA - 1996// TI - Assessing the minimal important difference in symptoms: a comparison of two techniques JO - J Clin Epidemiol VL - 49 UR - https://doi.org/10.1016/S0895-4356(96)00206-5 DO - 10.1016/S0895-4356(96)00206-5 ID - Redelmeier1996 ER - TY - JOUR AU - Jaeschke, R. AU - Singer, J. AU - Guyatt, G. H. PY - 1989 DA - 1989// TI - Measurement of health status. Ascertaining the minimal clinically important difference JO - Control Clin Trials VL - 10 UR - https://doi.org/10.1016/0197-2456(89)90005-6 DO - 10.1016/0197-2456(89)90005-6 ID - Jaeschke1989 ER -